Pharma companies are getting more serious about telehealth.
In the past three months,
Eli Lilly
launched a splashy website connecting consumers with places to get prescriptions for obesity, diabetes and migraine medications,
AstraZeneca
made its first virtual option for asthma patients and
Phathom
introduced a telehealth feature when launching its acid blocker marketing campaign.
Industry experts anticipate that offering consumers a direct way to reach prescriptions will become part of the future of drug marketing and commercialization. Consumers want to get prescription healthcare the way they get many other products — fast, easy and online. And there’s potential for broader access to medicines for remote patients.